Understanding these differences helps medical aestheticians select the ideal approach for each patient, balancing efficacy, comfort, and potential risks
Additionally, precautions are necessary for patients with previous pancreatitis or severe gastrointestinal disorders
After a median follow-up of 2.3 years, GLP-1 RAs users exhibit reduced risks of mortality (adjusted hazard ratio [aHR]: 0.57), MACEs (aHR: 0.88), and MAKEs (aHR: 0.73)
GLP-1RAs are synthetic molecules that mimic the effects of the naturally-occurring GLP-1 hormone, including increasing insulin secretion and slowing gastric emptying
[6] estimated the recidivism rate as 27.8% (ranging from 14 to 37%) at 7 years or more post SG
The cycle math below assumes one evening subcutaneous research-use draw per day from a 10 mg vial reconstituted with 2.0 mL bacteriostatic water